Collections: Health Policy and Services Research / Subjects: Government Regulation - Digital Collections - National Library of Medicine Search Results

Start Over Collections Health Policy and Services Research ✖ Subjects Government Regulation ✖ Publication Year 2022 to 2024 ✖

291. Notifying FDA of a permanent discontinuance or interruption in manufacturing of a device under Section 506J of the FD&C Act: guidance for industry and Food and Drug Administration staff

Publication:: Silver Spring, MD : Center for Devices and Radiological Health, November 17, 2023
Subject(s):: Correspondence as Topic
Device Approval
Government Regulation
Manufacturing Industry
United States
United States.

292. Assessing the credibility of computational modeling and simulation in medical device submissions: guidance for industry and Food and Drug Administration staff

Publication:: [Silver Spring, MD] : Center for Devices and Radiological Health, November 17, 2023
Subject(s):: Computer Simulation
Device Approval
Government Regulation
United States

293. Medicare Part D: CMS should monitor effects of rebates on plan formularies and beneficiary spending : report to congressional requesters

Publication:: Washington, DC : United States Government Accountability Office, September 2023
Subject(s):: Drug Costs
Government Regulation
Legislation, Medical
Medicare Part D -- economics
Medicare Part D -- organization & administration
Prescription Fees
United States
Centers for Medicare & Medicaid Services (U.S.)

294. CARES Act: experts identified safeguards to help selected HHS agencies protect against potential political interference : report to congressional requesters

Publication:: Washington, DC : United States Government Accountability Office, September 2023
Subject(s):: Government Regulation
Legislation, Medical
Politics
Professional Misconduct
United States
United States.
United States. Department of Health and Human Services

295. Medicare Part D: CMS should monitor effects of rebates on drug coverage and spending : testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives

Publication:: Washington, DC : United States Government Accountability Office, September 19, 2023
Subject(s):: Government Regulation
Legislation, Medical
Medicare Part D -- economics
Medicare Part D -- organization & administration
Prescription Drugs -- economics
United States

296. COVID-19 Provider Relief Fund: HRSA continues to recover remaining payments due from providers : report to congressional committees

Publication:: Washington, DC : United States Government Accountability Office, September 2023
Subject(s):: COVID-19
Disaster Planning -- economics
Disaster Planning -- organization & administration
Fraud -- prevention & control
Government Regulation
Health Personnel -- economics
Legislation, Medical
United States
United States. Health Resources and Services Administration

297. Medicaid program integrity: Opportunities exist for CMS to strengthen use of state auditor findings and collaboration : report to congressional requesters

Publication:: Washington, DC : United States Government Accountability Office, September 2023
Subject(s):: Financial Audit -- legislation & jurisprudence
Financial Audit -- trends
Government Programs
Government Regulation
Legislation, Medical
Medicaid
State Health Planning and Development Agencies
United States
Centers for Medicare & Medicaid Services (U.S.)

298. Nursing homes: Limitations of using CMS data to identify private equity and other ownership : report to the Ranking Member, Committee on Ways and Means, House of Representatives

Publication:: Washington, DC : United States Government Accountability Office, September 2023
Subject(s):: Data Accuracy
Government Regulation
Legislation, Medical
Nursing Homes -- economics
Nursing Homes -- legislation & jurisprudence
Nursing Homes -- organization & administration
United States
Centers for Medicare & Medicaid Services (U.S.)

299. COVID-19: USAID plans to share lessons learned from efforts to meet global vaccination goal : report to congressional addressees

Publication:: Washington, DC : United States Government Accountability Office, September 2023
Subject(s):: COVID-19 Vaccines -- supply & distribution
Global Health
Government Regulation
Immunization Programs
International Cooperation
Legislation, Medical
United States
United States. Agency for International Development

300. Tracking the funds. Specific fiscal year 2023 provisions for the Office of National Drug Control Policy

Publication:: [Washington, DC] : United States Government Accountability Office, September 2023
Subject(s):: Budgets
Government Programs -- economics
Government Regulation
Legislation, Medical
United States
United States. Office of National Drug Control Policy

« Previous
Next »
1
2
…
26
27
28
29
30
31
32
33
34
35
36